⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ERAS News
Erasca, Inc. Common Stock
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
globenewswire.com
ERAS
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
globenewswire.com
TNGX
ERAS
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
globenewswire.com
ERAS
Registration Momentum Builds Across the Oncology Pipeline
globenewswire.com
ACRV
KPTI
ERAS
ONCY
INCY
Erasca to Present at Upcoming Conferences in February
globenewswire.com
ERAS
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
globenewswire.com
ERAS
Erasca Announces Pricing of Upsized Public Offering of Common Stock
globenewswire.com
ERAS
Erasca Announces Proposed Public Offering of $150 Million of Common Stock
globenewswire.com
ERAS
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
prnewswire.com
GTBP
IBRX
ERAS
CHRS
NBP
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
prnewswire.com
ONCY
NRIX
ERAS
FHTX
ORIC